[227 Pages Report] The microbial identification market is expected to reach USD 3.00 Billion by 2022 from USD 2.04 Billion in 2016 at a CAGR of 6.6%. The base year for this study is 2016 and the forecast period is 2017�2022.

The objectives of this study are as follows:

To define, describe, and forecast the global market by product and service, method, application, end user, and region

To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders

To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)

To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies

To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product launches in the microbial identification market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product and service, method, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources such as World Health Organization, National Institutes of Health, Eurostat, Food and Drug Administration, Centers for Disease Control and Prevention, International Union of Microbiological Societies, The European Committee on Antimicrobial Susceptibility Testing, European Society of Clinical Microbiology and Infectious Diseases, European Diagnostic Manufacturers Association, American Society for Microbiology, and American Type Culture Collection have been used to identify and collect information useful for this extensive commercial study of the microbial identification market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the global market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The key players in the microbial identification include Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioM�rieux S.A. (France), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Bruker Corporation (US), Shimadzu Corporation (Japan), VWR Corporation (US), Eurofins Scientific S.E. (Luxembourg), GTCR, LLC. (US), QIAGEN N.V. (Netherlands), Liofilchem s.r.l. (Italy), IEH Laboratories & Consulting Group (US), Alcami Corporation (US), Biolog, Inc. (US), Abellon CleanEnergy Limited (India), Alpha Analytical, Inc. (US), NeoGenomics, Inc. (US), Trivitron Healthcare (India), Molzym GmbH & Co. KG (Germany), Dynatec Labs (US), Altogen Labs (US), STERIS plc (UK), and Wickham Laboratories Ltd. (UK).

Target Audience for this Report:

Academic and research institutes

Hospitals, clinics, and laboratories

Clinical research organizations (CROs)

Microbial identification service providers

Culture collection repositories

Diagnostic associations

Venture capitalists

Life sciences instrumentation and reagent companies

Business research and consulting firms

Government bodies

Microbial identification database and software providers

Venture capitalists

Scope of the Report:

This report categorizes the market into the following segments:

By Product and Services

Instruments Automated Microbial Identification Systems Mass Spectrometers PCR Microarrays High-power Microscopes Polystainers Flow Cytometers Other Instruments

Consumables Plates and Media Reagents and Kits Other Consumables

Services Identification Services Culture Collection Services



By Method

Phenotypic Methods

Genotypic Methods

Proteomics-based Methods

By Application

Diagnostic Applications Human Disease Diagnosis Animal Disease Diagnosis

Food Testing

Beverage Testing

Cosmetics and Personal Care Products Testing

Pharmaceutical Applications

Environmental Applications

Other Applications

By End User

Hospitals, Diagnostic Laboratories, and Blood Banks

Food Manufacturing Companies

Beverage Manufacturers

Pharmaceutical Companies and CROs

Other End Users

By Region

North America US Canada

Europe Germany France UK Rest of Europe

Asia Japan China India South Korea Rest of Asia

Rest of the World Latin America Brazil Rest of Latin America Other RoW countries



Customization Options:

Company Information: Detailed company profiles of five or more market players

Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

The global microbial identification market is expected to reach USD 3.00 Billion by 2022 from USD 2.18 Billion in 2017, at a CAGR of 6.6%. The market growth is primarily driven by the rising incidence of infectious diseases coupled with epidemic and pandemic outbreaks, increasing food safety concerns, technological advancements in microbial identification techniques, and government initiatives and funding to promote microbial identification.

The global market is segmented by product and service, method, application, end user, and regions. By product and service, the global market is segmented into instruments, consumables, and services. The instruments segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the extensive use of instruments and advances in technology to develop innovative instruments.

By method, the market is classified into phenotypic methods, proteomics-based methods, and genotypic methods. The phenotypic methods segment is estimated to account for the largest share of the global microbial identification market. The large share of this segment can be attributed to features like cost-effectiveness, ease of use, and ability to deliver results rapidly which lead to their increased adoption across different end users.

On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, and blood banks; food manufacturing companies; beverage manufacturing companies; pharmaceutical companies and CROs; and other end users. The hospitals, diagnostic laboratories, and blood banks segment is estimated to account for the largest share of the global market. Rising prevalence of various infectious diseases coupled with periodic outbreaks of pandemics and epidemics are major factors driving the growth of this end user segment.

The global microbial identification market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.

The factors such as the high cost of instruments and complex regulatory framework for the approval of new microbial diagnostic tests may restrain the market�s growth to a certain extent.

Major industry players launched innovative products to maintain and improve their position in the market. Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioM�rieux S.A. (France), and Bruker Corporation (US), Eurofins Scientific S.E. (Luxembourg) have been identified as the key players in microbial identification market . These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst